Stephens reissued their equal weight rating on shares of Anika Therapeutics (NASDAQ:ANIK – Get Rating) in a research report report published on Friday, Benzinga reports. The firm currently has a $28.00 target price on the biotechnology company’s stock. Several other research analysts have also recently commented on ANIK. StockNews.com started coverage on Anika Therapeutics in […]
Gary Fischetti Joins Anika Board Announces Share Repurchase Program Forms Capital Allocation Committee BEDFORD, Mass., April 13, 2023 (GLOBE NEWSWIRE).
Great West Life Assurance Co. Can bought a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,627 shares of the biotechnology company’s stock, valued at approximately $348,000. Other large […]
Anika Therapeutics (NASDAQ:ANIK – Get Rating) and Nemaura Medical (NASDAQ:NMRD – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Anika Therapeutics and Nemaura Medical’s […]